24.05.07 02:40 Il y a: 3 yrs
Ipsogen part of a 2.9 M€ granted European project dedicated to breast and colon cancer biomarker research - ‘COBRED project’
Categorie: Cancer du sein
IPSOGEN today announced that COBRED project coordinated by BioSystems International (Paris) has been awarded a 2.9 M€ grant as part of the 6th Framework Programme.
COBRED project aims at discovering breast cancer (BC) and colon cancer (CRC) biomarkers for patient follow-up (monitoring markers) by exploiting the capacity of 3 state-of-the-art high-throughput technologies in an integrated systems biology approach. In addition to Ipsogen, the consortium comprises 2 other biotechnology firms (BioSystems International, coordinator – Paris, France; Biocrates – Innsbrück, Austria), 2 large comprehensive cancer centres (Institut Curie - Paris, France; Institut Gustave Roussy, - Villejuif, France) and 3 academic partners (University of Debrecen, Hungary; University of Innsbrück, Austria; University of Tartu, Estonia); the consultancy firm ARTTIC (Paris, France) will support the consortium for project management.
Read more
